Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt/β-catenin pathway

Molecular and Cellular Biochemistry

Volumn 383, Issue 1-2, 2013, Pages 213-222

  Shen, Lihong ^a   Zhang, Xifeng ^a   Hu, Daixi ^a   Feng, Tao ^a   Li, Hongli ^a   Lu, Yongliang ^a   Huang, Jiayi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer stem cells; Hepatic progenitor cells; Hepatitis B virus X; WNT catenin pathway

Indexed keywords

BETA CATENIN; CASPASE 3; CASPASE 9; PROTEIN BAX; PROTEIN BCL 2; WNT PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATITIS B VIRUS; IMMUNOCYTOCHEMISTRY; LIVER CELL; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL;

ADENOVIRIDAE; HEPATITIS B VIRUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BETA CATENIN; GENE EXPRESSION REGULATION; HEK293 CELLS; HEPATOCYTES; HUMANS; MICE; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; RNA, MESSENGER; STEM CELLS; TRANS-ACTIVATORS; WNT SIGNALING PATHWAY;

EID: 84885429598     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1769-5     Document Type: Article

References (55)

1. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66(19):9339-9344. doi: 10.1158/0008-5472.CAN-06-3126
2. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367(6464):645-648. doi: 10.1038/367645a0
3. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730-737
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983-3988. doi: 10.1073/pnas.0530291100
5. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821-5828
6. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ (2004) Characterization of clonogenic multiple myeloma cells. Blood 103(6):2332-2336. doi: 10.1182/blood-2003-09-3064
7. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123):111-115. doi: 10.1038/nature05384
8. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65(23):10946-10951. doi: 10.1158/0008-5472.CAN-05-2018
9. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104(3):973-978. doi: 10.1073/pnas.0610117104
10. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65(20):9328-9337. doi: 10.1158/0008-5472. CAN-05-1343
11. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132(7):2542-2556. doi: 10.1053/j.gastro.2007.04.025
12. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM (2007) Identification of pancreatic cancer stem cells. Cancer Res 67(3):1030-1037. doi: 10.1158/0008-5472.CAN-06-2030
13. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15(3):504-514. doi: 10.1038/sj.cdd.4402283
14. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, Eberhart CG (2006) Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 66(15):7445-7452. doi: 10.1158/0008-5472.CAN- 06-0858
15. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H (2006) Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44(1):240-251. doi: 10.1002/hep.21227
16. Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J, Devereux WL, Rhodes JT, Huff CA, Beachy PA, Watkins DN, Matsui W (2007) Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 104(10):4048-4053. doi: 10.1073/pnas.0611682104
17. Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, Golub TR, Armstrong SA (2006) Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442(7104):818-822. doi: 10.1038/nature04980
18. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ (2005) Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 5(11):899-904. doi: 10.1038/nrc1740
19. Ganem D, Prince AM (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350(11):1118-1129. doi: 10.1056/NEJMra031087
20. Neuveut C, Wei Y, Buendia MA (2010) Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 52(4):594-604. doi: 10.1016/j.jhep.2009.10.033
21. Tang H, Delgermaa L, Huang F, Oishi N, Liu L, He F, Zhao L, Murakami S (2005) The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 79(9):5548-5556. doi: 10.1128/JVI.79.9.5548-5556.2005
22. Benhenda S, Cougot D, Buendia MA, Neuveut C (2009) Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 103:75-109. doi: 10.1016/S0065-230X(09)03004-8
23. Sell S (1993) The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma. Int J Dev Biol 37(1):189-201
24. Arzumanyan A, Friedman T, Ng IO, Clayton MM, Lian Z, Feitelson MA (2011) Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res 71(10):3701-3708. doi: 10.1158/0008-5472.CAN-10-3951
25. Zhang WY, Cai N, Ye LH, Zhang XD (2009) Transformation of human liver L-O2 cells mediated by stable HBx transfection. Acta Pharmacol Sin 30(8):1153-1161. doi: 10.1038/aps.2009.99
26. Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, Wu FQ, Zhang HL, Yu LX, Zheng LY, Li YQ, Dong W, He YQ, Liu Q, Zou SS, Lin Y, Hu L, Li Z, Wu MC, Wang HY (2011) HBx induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) treated HBx transgenic mice. Hepatology. doi: 10.1002/hep.24675
27. Huang J, Shen L, Lu Y, Li H, Zhang X, Hu D, Feng T, Song F (2012) Parallel induction of cell proliferation and inhibition of cell differentiation in hepatic progenitor cells by hepatitis B virus X gene. Int J Mol Med 30(4):842-848. doi: 10.3892/ijmm.2012.1060
28. Huang J, Bi Y, Zhu GH, He Y, Su Y, He BC, Wang Y, Kang Q, Chen L, Zuo GW, Luo Q, Shi Q, Zhang BQ, Huang A, Zhou L, Feng T, Luu HH, Haydon RC, He TC, Tang N (2009) Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int 29(10):1569-1581. doi: 10.1111/j.1478-3231.2009.02111.x
29. Bi Y, Huang J, He Y, Zhu GH, Su Y, He BC, Luo J, Wang Y, Kang Q, Luo Q, Chen L, Zuo GW, Jiang W, Liu B, Shi Q, Tang M, Zhang BQ, Weng Y, Huang A, Zhou L, Feng T, Luu HH, Haydon RC, He TC, Tang N (2009) Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. J Cell Biochem 108(1):295-303. doi: 10.1002/jcb.22254
30. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL (2003) Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase. J Biol Chem 278(34):31807-31813. doi: 10.1074/jbc.M302580200
31. Takada S, Kaneniwa N, Tsuchida N, Koike K (1997) Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 15(16):1895-1901. doi: 10.1038/sj.onc.1201369
32. Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD (2001) X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J Biol Chem 276(11):8328-8340. doi: 10.1074/jbc.M006026200
33. Kim KH, Seong BL (2003) Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J 22(9):2104-2116. doi: 10.1093/emboj/cdg210
34. Su F, Schneider RJ (1997) Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 94(16):8744-8749
35. Hu M, Kurobe M, Jeong YJ, Fuerer C, Ghole S, Nusse R, Sylvester KG (2007) Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology 133(5):1579-1591. doi: 10.1053/j.gastro.2007.08.036
36. Apte U, Thompson MD, Cui S, Liu B, Cieply B, Monga SP (2008) Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology 47(1):288-295. doi: 10.1002/hep.21973
37. Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu LX, Zhang SH, Huang DD, Tang L, Kong XN, Chen C, Liu SQ, Wu MC, Wang HY (2008) Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 68(11):4287-4295. doi: 10.1158/0008-5472.CAN-07-6691
38. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL (2000) Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem 275(33):25858-25864. doi: 10.1074/jbc.M003578200
39. Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC (2001) Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Oncogene 20(28):3620-3628. doi: 10.1038/sj.onc.1204495
40. Gottlob K, Fulco M, Levrero M, Graessmann A (1998) The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem 273(50):33347-33353
41. Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, Reed JC (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22(11):2729-2740. doi: 10.1093/emboj/cdg263
42. Lee YI, Hwang JM, Im JH, Kim NS, Kim DG, Yu DY, Moon HB, Park SK (2004) Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem 279(15):15460-15471. doi: 10.1074/jbc. M309280200
43. Waris G, Huh KW, Siddiqui A (2001) Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 21(22):7721-7730. doi: 10.1128/MCB.21.22.7721-7730.2001
44. Kim S, Kim HY, Lee S, Kim SW, Sohn S, Kim K, Cho H (2007) Hepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and dynein-dependent manners. J Virol 81(4):1714-1726. doi: 10.1128/JVI.01863-06
45. Shirakata Y, Koike K (2003) Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J Biol Chem 278(24):22071-22078. doi: 10.1074/jbc.M301606200
46. Pan J, Duan LX, Sun BS, Feitelson MA (2001) Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B. J Gen Virol 82(Pt 1):171-182
47. Protzer U, Seyfried S, Quasdorff M, Sass G, Svorcova M, Webb D, Bohne F, Hosel M, Schirmacher P, Tiegs G (2007) Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 133(4):1156-1165. doi: 10.1053/j.gastro.2007.07.021
48. Lee YI, Kang-Park S, Do SI (2001) The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 276(20):16969-16977. doi: 10.1074/jbc.M011263200
49. Liu Q, Chen J, Liu L, Zhang J, Wang D, Ma L, He Y, Liu Y, Liu Z, Wu J (2011) The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production. J Biol Chem 286(19):17168-17180. doi: 10.1074/jbc.M110.167783
50. Liu H, Yuan Y, Guo H, Mitchelson K, Zhang K, Xie L, Qin W, Lu Y, Wang J, Guo Y, Zhou Y, He F (2012) Hepatitis B virus encoded X protein suppresses apoptosis by inhibition of the caspase-independent pathway. J Proteome Res 11(10):4803-4813. doi: 10.1021/pr2012297
51. Nejak-Bowen KN, Monga SP (2011) Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol 21(1):44-58. doi: 10.1016/j.semcancer.2010.12.010
52. Cavard C, Colnot S, Audard V, Benhamouche S, Finzi L, Torre C, Grimber G, Godard C, Terris B, Perret C (2008) Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol 4(5):647-660. doi: 10.2217/14796694.4.5.647
53. Gheorghiade M, Palazzuoli A, Ronco C (2010) Acute heart failure treatment: traditional and new drugs. Contrib Nephrol 165:112-128 Retraction in Contrib Nephrol 167:VI
54. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398(6726):422-426. doi: 10.1038/18884
55. Orford K, Orford CC, Byers SW (1999) Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol 146(4):855-868